Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Johnson & Johnson JNJ

Healthcare  —  Drug Manufacturers General
271.22 0.54 0.20% as of 25 Sep
Market cap
$652.8B
P/E
31.4×
S&P 500 Member Dividend Aristocrat Cash Flow Champion (3y) Revenue Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Johnson & Johnson (JNJ) Price to free cash flow

As of 25 September 2026, Johnson & Johnson (JNJ) trades at a price to free cash flow of 28.7×. Over the past ten years it has ranged from 12.7× (March 2020) to 34.1× (June 2026); the current reading is higher than 96% of that period. That is above the Drug Manufacturers General industry median of 17.7× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 24.4× 43.80%
FY2024 17.0× (22.10%)
FY2023 21.8× (17.45%)
FY2022 26.4× 19.95%
FY2021 22.0× 8.80%
FY2020 20.2× 21.48%
FY2019 16.6× 4.53%
FY2018 15.9× (16.70%)
FY2017 19.1× 1.32%
FY2016 18.9× 29.67%

Quarterly

Period Price to free cash flow Change
Jun 2026 26.9× (16.58%)
Mar 2026 32.3× 32.19%
Dec 2025 24.4× 9.60%
Sep 2025 22.3× 14.98%
42 more quarters

Against its own ten years

Low 12.7× High 34.1×
Ten-year median 19.1×
Current reading's percentile 96

Price to free cash flow against peers

Company Price to free cash flow
GILD Gilead Sciences, Inc. compare 14.5×
PFE Pfizer Inc. compare 16.0×
NVS Novartis AG compare 18.3×
MRK Merck & Co., Inc. compare 22.9×
AMGN Amgen Inc. compare 23.0×
ABBV AbbVie Inc. compare 25.7×
JNJ Johnson & Johnson 28.7×
AZN AstraZeneca PLC compare 41.2×
LLY Eli Lilly and Company compare 51.8×
Drug Manufacturers General industry median 17.7×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on JNJ